Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Life-threatening
100%
Immunosuppression
100%
Cytokine Release Syndrome
100%
Life-threatening Complications
50%
Interferon-α (IFN-α)
50%
Therapeutic Implications
50%
Corticosteroids
50%
Immunosuppressive Therapy
50%
Uncontrolled Study
50%
Interleukin-6
50%
Optimal Management
50%
Treatment Algorithm
50%
Adoptive Cell Therapy
50%
Circulating Levels
50%
Interleukin-6 Inhibitors
50%
Bispecific Antibody
50%
Immune Therapy
50%
Tocilizumab
50%
Natural Antibodies
50%
Algorithm for Management
50%
Immunology and Microbiology
Immunotherapy
100%
Immunosuppression
100%
Cytokine Release Syndrome
100%
Cytokine
50%
interferon
50%
Receptor Antibody
50%
Interleukin 6
50%
Interleukin-6 Receptor
50%
Bispecific Antibody
50%
Immunosuppressive Therapy
50%
Tocilizumab
50%
Adoptive T Cell Therapy
50%
Nursing and Health Professions
Immunosuppressive Treatment
100%
Cytokine Release Syndrome
100%
Malignant Neoplasm
66%
Syndrome
66%
Immunotherapy
66%
Corticosteroid
33%
Interleukin 6
33%
Interferon
33%
Interleukin 6 Receptor
33%
Cell Therapy
33%
Receptor Antibody
33%
Tocilizumab
33%
Bispecific Antibody
33%
Efficacy
33%
Cytokine
33%
Medicine and Dentistry
Immunosuppressive Treatment
100%
Cytokine Release Syndrome
100%
Malignant Neoplasm
66%
Immunotherapy
66%
Cytokine
33%
Interferon
33%
T Cell
33%
Interleukin 6
33%
Cell Therapy
33%
Bispecific Antibody
33%
Interleukin 6 Receptor
33%
Receptor Antibody
33%
Tocilizumab
33%
Corticosteroid
33%